1. Home
  2. LNTH vs RNST Comparison

LNTH vs RNST Comparison

Compare LNTH & RNST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Lantheus Holdings Inc.

LNTH

Lantheus Holdings Inc.

HOLD

Current Price

$63.42

Market Cap

3.8B

Sector

Health Care

ML Signal

HOLD

RNST

Renasant Corporation

HOLD

Current Price

$36.34

Market Cap

3.3B

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
LNTH
RNST
Founded
1956
1904
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Major Banks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
3.8B
3.3B
IPO Year
2015
N/A

Fundamental Metrics

Financial Performance
Metric
LNTH
RNST
Price
$63.42
$36.34
Analyst Decision
Buy
Strong Buy
Analyst Count
6
6
Target Price
$74.17
$43.17
AVG Volume (30 Days)
1.1M
484.8K
Earning Date
11-06-2025
10-28-2025
Dividend Yield
N/A
2.53%
EPS Growth
N/A
N/A
EPS
2.39
1.84
Revenue
$1,525,933,000.00
$775,309,000.00
Revenue This Year
$0.01
$43.37
Revenue Next Year
$1.24
$13.13
P/E Ratio
$26.45
$19.79
Revenue Growth
1.95
13.04
52 Week Low
$47.25
$26.97
52 Week High
$111.29
$40.40

Technical Indicators

Market Signals
Indicator
LNTH
RNST
Relative Strength Index (RSI) 71.16 62.21
Support Level $57.44 $35.16
Resistance Level $59.30 $36.18
Average True Range (ATR) 2.14 0.80
MACD 0.82 0.25
Stochastic Oscillator 91.35 96.11

Price Performance

Historical Comparison
LNTH
RNST

About LNTH Lantheus Holdings Inc.

Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.

About RNST Renasant Corporation

Renasant Corp operates as a holding company for Renasant Bank, a Mississippi banking corporation, and its subsidiary, Renasant Insurance, Inc. It has three reportable segments: Community banks, Insurance, and Wealth management. With its Community banks segment, the company provides a range of financial services to individuals and small businesses. Its Insurance segment is an insurance agency providing commercial and personal insurance through third-party carriers. The Wealth management segment provides a range of services, including money management and retirement planning. The majority of the company's revenue is driven by lending activities in its community banks segment.

Share on Social Networks: